BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 23656651)

  • 1. Genetically informed therapy in leukemia.
    Radich J
    N Engl J Med; 2013 May; 368(19):1838-9. PubMed ID: 23656651
    [No Abstract]   [Full Text] [Related]  

  • 2. CSF3R is mutated in chronic neutrophilic leukemia and atypical CML.
    Cancer Discov; 2013 Jul; 3(7):OF23. PubMed ID: 23847367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [New mutations in myeloproliferative neoplasms; 2014 update].
    Kirito K
    Rinsho Ketsueki; 2014 Oct; 55(10):1833-40. PubMed ID: 25297747
    [No Abstract]   [Full Text] [Related]  

  • 4. [Molecular characterization of atypical chronic myeloid leukemia and chronic neutrophilic leukemia].
    Senín A; Arenillas L; Martínez-Avilés L; Fernández-Rodríguez C; Bellosillo B; Florensa L; Besses C; Álvarez-Larrán A
    Med Clin (Barc); 2015 Jun; 144(11):487-90. PubMed ID: 24854193
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oncogenic CSF3R mutations in chronic neutrophilic leukemia and atypical CML.
    Maxson JE; Gotlib J; Pollyea DA; Fleischman AG; Agarwal A; Eide CA; Bottomly D; Wilmot B; McWeeney SK; Tognon CE; Pond JB; Collins RH; Goueli B; Oh ST; Deininger MW; Chang BH; Loriaux MM; Druker BJ; Tyner JW
    N Engl J Med; 2013 May; 368(19):1781-90. PubMed ID: 23656643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent Progress in Chronic Neutrophilic Leukemia and Atypical Chronic Myeloid Leukemia.
    Dao KT; Tyner JW; Gotlib J
    Curr Hematol Malig Rep; 2017 Oct; 12(5):432-441. PubMed ID: 28983816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. What's different about atypical CML and chronic neutrophilic leukemia?
    Dao KH; Tyner JW
    Hematology Am Soc Hematol Educ Program; 2015; 2015():264-71. PubMed ID: 26637732
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The new genetics of chronic neutrophilic leukemia and atypical CML: implications for diagnosis and treatment.
    Gotlib J; Maxson JE; George TI; Tyner JW
    Blood; 2013 Sep; 122(10):1707-11. PubMed ID: 23896413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genomics of chronic neutrophilic leukemia.
    Maxson JE; Tyner JW
    Blood; 2017 Feb; 129(6):715-722. PubMed ID: 28028025
    [TBL] [Abstract][Full Text] [Related]  

  • 10. De novo CSF3R mutation associated with transformation of myeloproliferative neoplasm to atypical CML.
    Bartels S; Lehmann U; Büsche G; Schlue J; Hussein K; Debatin D; Karcher A; Andrulis M; Schirmacher P; Kreipe H
    Ann Hematol; 2015 Jul; 94(7):1255-6. PubMed ID: 25865944
    [No Abstract]   [Full Text] [Related]  

  • 11. Molecular genetics of chronic neutrophilic leukemia, chronic myelomonocytic leukemia and atypical chronic myeloid leukemia.
    Li B; Gale RP; Xiao Z
    J Hematol Oncol; 2014 Dec; 7():93. PubMed ID: 25498990
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specific molecular mutation patterns delineate chronic neutrophilic leukemia, atypical chronic myeloid leukemia, and chronic myelomonocytic leukemia.
    Meggendorfer M; Haferlach T; Alpermann T; Jeromin S; Haferlach C; Kern W; Schnittger S
    Haematologica; 2014 Dec; 99(12):e244-6. PubMed ID: 25239264
    [No Abstract]   [Full Text] [Related]  

  • 13. CSF3R-mutant chronic myelomonocytic leukemia is a distinct clinically subset with abysmal prognosis: a case report and systematic review of the literature.
    Guastafierro V; Ubezio M; Manes N; Milanesi C; Della Porta M; Bonometti A
    Leuk Lymphoma; 2023 Sep; 64(9):1566-1573. PubMed ID: 37395413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The CSF3R T618I mutation causes a lethal neutrophilic neoplasia in mice that is responsive to therapeutic JAK inhibition.
    Fleischman AG; Maxson JE; Luty SB; Agarwal A; Royer LR; Abel ML; MacManiman JD; Loriaux MM; Druker BJ; Tyner JW
    Blood; 2013 Nov; 122(22):3628-31. PubMed ID: 24081659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atypical CML with mutated SRSF2, ASXL1, CSF3R, and MPL.
    Tran A; Wong M
    Blood; 2021 Dec; 138(26):2890. PubMed ID: 34967865
    [No Abstract]   [Full Text] [Related]  

  • 16. The CSF3R T618I mutation as a disease-specific marker of atypical CML post allo-SCT.
    Langabeer SE; McCarron SL; Haslam K; O'Donovan MT; Conneally E
    Bone Marrow Transplant; 2014 Jun; 49(6):843-4. PubMed ID: 24614839
    [No Abstract]   [Full Text] [Related]  

  • 17. Chronic neutrophilic leukemia in a child with a CSF3R T618I germ line mutation.
    Druhan LJ; McMahon DP; Steuerwald N; Price AE; Lance A; Gerber JM; Avalos BR
    Blood; 2016 Oct; 128(16):2097-2099. PubMed ID: 27581359
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical response to ruxolitinib in CSF3R T618-mutated chronic neutrophilic leukemia.
    Stahl M; Xu ML; Steensma DP; Rampal R; Much M; Zeidan AM
    Ann Hematol; 2016 Jun; 95(7):1197-200. PubMed ID: 27068405
    [No Abstract]   [Full Text] [Related]  

  • 19. [Chronic neutrophilic leukemia with CSF3R mutation and concurrent multiple myeloma: one case report].
    He M; Zhao XC; Bai H
    Zhonghua Xue Ye Xue Za Zhi; 2019 Dec; 40(12):1052. PubMed ID: 32023742
    [No Abstract]   [Full Text] [Related]  

  • 20. Inherited transmission of the CSF3R T618I mutational hotspot in familial chronic neutrophilic leukemia.
    Duployez N; Willekens C; Plo I; Marceau-Renaut A; de Botton S; Fenwarth L; Boyer T; Huet G; Nibourel O; Rose C; Nelken B; Quesnel B; Preudhomme C
    Blood; 2019 Dec; 134(26):2414-2416. PubMed ID: 31697825
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.